Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOX · Real-Time Price · USD
4.550
-0.190 (-4.01%)
Feb 21, 2025, 4:00 PM EST - Market closed
Bioceres Crop Solutions Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Bioceres Crop Solutions stock have an average target of 9.88, with a low estimate of 6.50 and a high estimate of 13. The average target predicts an increase of 117.14% from the current stock price of 4.55.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bioceres Crop Solutions stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $7 → $6.5 | Strong Buy | Maintains | $7 → $6.5 | +42.86% | Feb 13, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +75.82% | Feb 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9.5 → $7 | Strong Buy | Maintains | $9.5 → $7 | +53.85% | Feb 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | +163.74% | Jan 28, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $9.5 | Strong Buy | Maintains | $10 → $9.5 | +108.79% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
390.32M
from 464.83M
Decreased by -16.03%
Revenue Next Year
419.78M
from 390.32M
Increased by 7.55%
EPS This Year
-0.04
from 0.05
EPS Next Year
0.18
from -0.04
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 416.5M | 444.2M | 600.0M | ||
| Avg | 390.3M | 419.8M | 582.8M | ||
| Low | 366.8M | 392.1M | 560.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -10.4% | 13.8% | 42.9% | ||
| Avg | -16.0% | 7.5% | 38.8% | ||
| Low | -21.1% | 0.5% | 33.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.08 | 0.32 | 0.89 | ||
| Avg | -0.04 | 0.18 | 0.87 | ||
| Low | -0.11 | 0.06 | 0.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 64.4% | - | 386.1% | ||
| Avg | - | - | 372.2% | ||
| Low | - | - | 353.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.